2025 annual financial data

Corbus Pharmaceuticals Holdings 2025 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -85.31M USD and net income was -78.54M USD.
Operating cash flow was -64.49M USD.

Get free Corbus Pharmaceuticals Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-85.31M USD
Net income
-78.54M USD
Operating cash flow
-64.49M USD